Repligen Corporation (NASDAQ:RGEN) Q1 2024 Earnings Call Transcript
Repligen Corporation misses on earnings expectations. Reported EPS is $0.28 EPS, expectations were $0.29.
Repligen Corp (RGEN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 681,020 | $124,514,760 | -26% | 0.47% |
| 2. | 12 West Capital Management Joel Ramin | 252,849 | $46,503,988 | -32% | 4.19% |
| 3. | Zevenbergen Capital Investments Nancy Zevenbergen | 130,607 | $24,021,239 | +1% | 0.5% |
| 4. | Lee Munder Capital Group Lee Munder | 3,538 | $650,709 | -30% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $156.18 | 500 | Director | 1,611 | 2023-05-08 | Filing | |
| $159.19 | 500 | Director | 1,111 | 2023-05-05 | Filing | |
| $161.15 | 500 | Director | 611 | 2023-05-04 | Filing | |
| $175.02 | 625 | Director | 2,106 | 2022-03-16 | Filing | |
| $3.05 | 25,000 | Officer | 151,270 | 2014-04-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $193.73 | 3,517 | 24,260 | 2024-03-11 | Filing | ||
| $202.55 | 156 | 185,249 | 2024-03-08 | Filing | ||
| $201.75 | 806 | 185,405 | 2024-03-08 | Filing | ||
| $200.56 | 1,305 | 186,211 | 2024-03-08 | Filing | ||
| $199.53 | 1,822 | 187,516 | 2024-03-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,859,645 | $1,413,164,160 | 0.03% | |
| 2. | 5,078,294 | $913,077,261 | 0.01% | |
| 3. | 1,882,516 | $338,476,332 | 0.02% | |
| 4. | 1,703,618 | $306,310,516 | 0.01% | |
| 5. | 1,568,792 | $282,068,677 | 0.32% |
News See All
Should be Confident in Repligen Corporation (RGEN)’s Long-Term Growth Potential?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Repligen Corporation (NASDAQ:RGEN) Q4 2023 Earnings Call Transcript
Repligen Corporation reports earnings inline with expectations. Reported EPS is $0.33 EPS, expectations were $0.33.
Here’s Why Repligen Corporation (RGEN) Rose 13% in Q3
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.
Does Repligen Corp. (RGEN) Have a Bright Future?
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Growth Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Repligen Corporation (NASDAQ:RGEN) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Repligen’s 2023 Third Quarter Earnings Conference Call. My name is Keith, and I will be your coordinator.
Reasons For the Decline of Repligen Corporation (RGEN)
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
What Makes Repligen Corporation (RGEN) a Quality Investment?
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here.
Multiple Headwinds Impacted Repligen Corp. (RGEN)’s Performance in Q2
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Growth Strategy” second-quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
